Vaccines Against Malaria (1996) / Chapter Skim
Currently Skimming:
6 Solutions for Coordination
6 Solutions for Coordination
Pages 19-23
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 19... ...
The board should monitor progress in malaria vaccine development in both the public and private sectors; identify development needs, opportunities, and priorities and advise interested parties and funding agencies of these findings; provide financial and other support for high-priority development efforts; and encourage collaboration among academia and private and public sector entities. To succeed, the board must: 1.
|
From page 20... ...
malaria vaccine development efforts and in coordinating these with international academic researchers, corporations, and relevant organizations such as the World Health Organization, the World Bank, the United Nations Development Programme, and the Commission of the European Communities. While there are historical precedents for aspects of the proposed Malaria Vaccine Development Board, none completely covers all of the facets described above.
|
From page 21... ...
The task force consisted of 15 members from academia, industry, and community constituency groups; the directors of the National Institutes of Health and Federal Drug Administration; and the assistant secretary for health, who acted as chair. The task force forwarded a series of recommendations to the secretary for health, DIMS, that focused on incentives for increased involvement of industry and academia in AIDS drug discovery and development efforts.
|
From page 22... ...
In such instances, it is important that the individual agencies coordinate their efforts, capabilities, and resources within the larger context of vaccine R&D. Prioritization, Product Development, and Process Management At the simplest level, coordinated malaria vaccine R&D requires participants to distinguish more promising malaria vaccine candidates from those with less promise, and to guide the most promising candidates through the development process.
|
From page 23... ...
By consensus, participants began to focus on more proactive efforts to accelerate malaria vaccine R&D through increased collaboration and cooperation among the participants. Several task forces charged with development of selected malaria vaccine products were established and have begun to coordinate the steps in the development process.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.